fig2
Figure 2. Summary of the different pathways involved in the anti-HCC activity of luteolin (created with BioRender.com). ↑: increase; ↓: decrease. HCC: Hepatocellular carcinoma; SIRT1: sirtuin 1 protein; Cdk2: cyclin-dependent kinase 2; NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells; TGF: transforming growth factor.
